Enterococcal bacteremia in the surgical intensive care unit: Does vancomycin resistance affect mortality?

Archives of Surgery

Volumn 132, Issue 1, 1997, Pages 76-81

  Mainous, Mark R ^b   Lipsett, Pamela A ^a   O'Brien, Maureen ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; ENTEROCOCCUS; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

EID: 0031032132     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430250078017     Document Type: Article

References (15)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infections. Am J Med. 1991;91(suppl 3B):72S-75S.
2. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States 1980-1989. Am J Med. 1991; 91 (suppl 3B):86S-89S.
3. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet. 1988;1:57-58.
4. LeClercq R, Derlot E, Weber M, Duval J, Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1989;33:10-15.
5. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992;93:195-198.
6. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993;42:597-599.
7. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995; 172:993-1000.
8. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis. 1995;21:45-50.
9. Facklam RL, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989;27: 731-734.
10. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20: 1126-1133.
11. Moreno F, Grota P, Crisp C, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis. 1995;21:1234-1237.
12. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev. 1990; 3:46-65.
13. Yagi Y, Clewell DB. Plasmid-determined tetracycline resistance in Streptococcus faecalis: tandemly repeated resistance determinants in amplified forms of PAMB1 DNA. J Mol Biol. 1976;102:583-600.
14. French G, Abdulla Y, Heathcock R, Poston S, Cameron J. Vancomycin resistance in south London. Lancet. 1992;339:818-819.
15. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. MMWR Morb Mortal Wkly Rep. 1995;44:1-13.